Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: A case-control study

Thorax

Volumn 70, Issue 4, 2015, Pages 320-325

  Fowler, Stephen J ^a,b   Basanta Sanchez, Maria ^a   Xu, Yun ^a   Goodacre, Royston ^a   Dark, Paul M ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CULTURE; BREATH ANALYSIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; EMERGENCY CARE; FEMALE; GAS CHROMATOGRAPHY; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT; MALE; METABOLOMICS; MICROORGANISM DETECTION; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; TIME OF FLIGHT MASS SPECTROMETRY; TRACHEOBRONCHIAL TOILET; VALIDATION PROCESS; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; AGED; EVALUATION STUDY; EXHALATION; HEALTH SURVEY; INTENSIVE CARE; LONGITUDINAL STUDY; LUNG LAVAGE; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROCEDURES;

ADULT; AGED; BREATH TESTS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; EXHALATION; FEMALE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LONGITUDINAL STUDIES; MALE; METABOLOMICS; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; POPULATION SURVEILLANCE;

EID: 84925654833     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-206273     Document Type: Article

References (24)

1. National Audit Office. Comptroller and auditor general: Reducing healthcare associated infection in hospitals in England. London: National Audit Office, 2009. Contract No.: HC 560.
2. Davies SC. Annual Report of the Chief Medical Officer, Volume Two, 2011, infections and the rise of antimicrobial resistance. London: Department of Health, 2013.
3. Zimlichman E, Henderson D, Tamir O, et al. Health care-Associated infections: A meta-Analysis of costs and financial impact on the US health care system. JAMA Intern Med 2013; 173: 2039-46.
4. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-Acquired, ventilator-Associated, and healthcare-Associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
5. Felton T, Mount T, Chadwick P, et al. Surveillance non-directed bronchial lavage allows confident use of focused antibiotics in the management of ventilator-Associated pneumonia. J Infect 2010; 60: 397-9.
6. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-The need for global solutions. Lancet Infect Dis 2013; 13: 1057-98.
7. World Health Organization. The evolving threat of antimicrobial resistance: Options for action. Geneva: World Health Organization, 2012.
8. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228.
9. Bos LD, Sterk PJ, Schultz MJ. Volatile metabolites of pathogens: A systematic review. PLoS Pathog 2013; 9: E1003311.
10. Ibrahim B, Basanta M, Cadden P, et al. Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax 2011; 66: 804-9.
11. Motta A, Paris D, Melck D, et al. Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: Methodological aspects. Eur Respir J 2012; 39: 498-500.
12. Syhre M, Scotter JM, Chambers ST. Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol 2008; 46: 209-15.
13. Members MSIB, Sansone SA, Fan T, et al. The metabolomics standards initiative. Nat Biotechnol 2007; 25: 846-8.
14. Basanta M, Jarvis RM, Xu Y, et al. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst 2010; 135: 315-20.
15. Xu Y, Fowler SJ, Bayat A, et al. Chemometrics models for overcoming high between subject variability: Applications in clinical metabolic profiling studies. Metabolomics 2014; 10: 375-85.
16. Broadhurst D, Kell D. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006; 2: 171-96.
17. Sumner L, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis. Metabolomics 2007; 3: 211-21.
18. Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-Associated pneumonia. Thorax 2010; 65: 201-7.
19. Rai R, Azim A, Sinha N, et al. Metabolic profiling in human lung injuries by high-resolution nuclear magnetic resonance spectroscopy of bronchoalveolar lavage fluid (BALF). Metabolomics 2013; 9: 667-76.
20. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 1994; 17: 127-60.
21. Phillips M, Cataneo RN, Greenberg J, et al. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J Lab Clin Med 2000; 136: 243-9.
22. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-28.
23. Bos LD, Schultz MJ, Sterk PJ. Exhaled breath profiling for diagnosing acute respiratory distress syndrome. BMC Pulm Med 2014; 14: 72.
24. Montuschi P, Mores N, Trove A, et al. The electronic nose in respiratory medicine. Respiration 2013; 85: 72-84.